XI International Conference on Human Retrovirology: HTLV

描述（由申请人提供）：HTLV-I和HTLV-II是在HIV之前发现的人类逆转录病毒。它们之所以重要，是因为它们1)在全世界感染多达1400万人（HTLV-I）和数百万人（HTLV-II）；2)引起血液学、神经系统和自身免疫性疾病（HTLV-I）和神经系统疾病，并增加对细菌感染的易感性（HTLV-II）；3)作为其他人类逆转录病毒感染（如艾滋病毒）的流行病学和发病机制的模型。人类逆转录病毒学国际会议：HTLV和相关病毒是两年一次的会议，旨在联合全球HTLV研究人员参加唯一专门研究HTLV感染的定期国际会议。来自HTLV流行地区和国际传染病研究机构的300至350名学者齐聚一堂，在这个两年一次的会议上介绍他们在HTLV感染的分子病毒学、免疫学、流行病学和临床结果方面的最新数据。从历史上看，该会议一直在htlv流行地区举行，如夏威夷、牙买加、特立尼达、巴西和日本东南部，或在巴黎和都柏林等国际研究中心举行。2002年的旧金山会议将是自1994年以来的第一次美国会议，组织者计划强调与旧金山和美国有关的研究主题，即与注射药物使用有关的HTLV-II和输血传播病毒感染。由于美国国内旅费较低，旧金山的会场将允许更多的美国青年科学家和学生参加，从而实现我们鼓励新一代HTLV研究人员的目标。为了鼓励来自HTLV感染流行的发展中国家的与会者继续积极参与，本赠款申请寻求支付会议费用并保持可负担的注册费。

DESCRIPTION (provided by applicant): HTLV-I and HTLV-II are human retroviruses discovered just prior to HIV. They are important because they 1) infect up to 14 million (HTLV-I) and several million (HTLV-II) people worldwide; 2) cause hematologic, neurologic and autoimmune disease (HTLV-I) and neurologic disease together with increased susceptibility to bacterial infections (HTLV-II); and 3) serve as models for the epidemiology and pathogenesis of other human retroviral infections such as HIV. The International Conference on Human Retrovirology: HTLV and Related Viruses is a biennial conference which serves to unite the global community of HTLV researchers at the only regular international meeting devoted exclusively to HTLV infection. Three hundred to 350 scholars from HTLV-endemic regions and international infectious disease research institutions gather at this biennial meeting to present their latest data on the molecular virology, immunology, epidemiology and clinical outcomes of HTLV infection. Historically the meeting has been held in HTLV-endemic areas such as Hawaii, Jamaica, Trinidad, Brazil, and southeastern Japan, or at international research centers such as Paris and Dublin. The 2002 meeting planned for San Francisco will be the first USA meeting since 1994, and the organizers plan to emphasize research themes relevant to San Francisco and the USA, namely injection drug use-related HTLV-II and transfusion transmission viral infections. The San Francisco venue will allow more US junior scientists and students to attend due to lower domestic travel costs, fulfilling our goal of encouraging a new generation of HTLV researchers. In order to encourage the continued strong participation of attendees from developing countries with endemic HTLV infection, this grant application seeks to defray meeting expenses and keep registration fees affordable. The objectives for the XI Conference on Human Retrovirology: HTLV and related Viruses in San Francisco are: To provide a forum for the presentation of original research pertaining to HTLV-I, HTLV-II and related human and primate viruses; To promote interdisciplinary interaction between basic scientists, epidemiologists and clinical researchers toward fostering "bench to bedside" research; To promote interaction between scientists in the developed and developing world, and to stimulate international collaboration; and To expose students and young scientists to the HTLV research arena and promote their research careers.